Public-registry site landscape for NCT04470726, a Superficial Basal Cell Carcinoma study sponsored by AiViva BioPharma, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04470726 (registry record) |
| Sponsor | AiViva BioPharma, Inc. |
| Condition(s) | Superficial Basal Cell Carcinoma; Nodular Basal Cell Carcinoma; Nonmelanoma Skin Cancers |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 4 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT04470726 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →